Connect with us

Published

2 months ago

on

A man wearing Abbott’s Lingo biosensor.

Courtesy of Abbott

Abbott Laboratories announced Thursday its over-the-counter continuous glucose monitor Lingo is available in the U.S. starting at $49. 

Lingo is part of an emerging class of consumer-friendly biosensors that people can use to learn how their bodies respond to food, exercise, sleep and stress. These devices, called continuous glucose monitors, are small sensors that stick through the skin to measure real-time glucose levels. Glucose is a sugar molecule that comes from food, and it’s the body’s main energy source.

Continuous glucose monitors have served as tools for patients with diabetes, but Lingo is not intended for diabetes management. Instead, it’s designed for adults who do not take insulin and want to “improve their overall health and wellness,” according to a release. 

Everyone’s glucose levels fluctuate, but consistently high levels can cause more serious health problems like metabolic disease, insulin resistance and heart disease, Abbott said. The company argues Lingo can educate users about existing habits and help them learn to manage their glucose in healthier ways.

“That’s really the goal, is to not only see and understand what’s happening inside your body, but to be able to improve on that, to be able to build these healthy habits that drive those changes,” Ben Fohner, the director of Abbott’s Lingo app, told CNBC in an interview. 

Abbott already offers continuous glucose monitors for diabetes patients in the U.S., so the company is looking to break into an entirely new market with Lingo. About 1 in 3 Americans have prediabetes, for instance, but these patients typically don’t qualify for prescriptions or insurance coverage for the monitors. 

Now, they can pay for the sensors out of pocket without a prescription. Users can buy one sensor online for $49, two sensors for $89 or six sensors for $249, Abbott said. Each sensor is worn on the upper arm for up to 14 days. 

Olivier Ropars, Abbott’s divisional vice president of Lingo, said the company decided to offer three different pricing options so curious consumers won’t feel intimidated by a lengthy commitment. A customer can opt to buy just one sensor to try for a couple of weeks.

“We want to make it as accessible and affordable as possible,” Ropars told CNBC in an interview. 

Abbott’s competitor, Dexcom, is also eyeing the prediabetes market. The company released its over-the-counter continuous glucose monitor geared toward this demographic in late August. Dexcom’s device is called Stelo, and is available in the U.S. for $89 a month. Patients with Type 2 diabetes who do not take insulin can also use it, the company said.

The U.S. Food and Drug Administration approved Dexcom’s Stelo in March, and it cleared two over-the-counter continuous glucose monitoring systems from Abbott in June. One of Abbott’s systems was Lingo, and the second system, called Libre Rio, is intended for patients with Type 2 diabetes who do not take insulin.

Though Type 2 patients who are not taking insulin could technically use Lingo, Ropars said Abbott’s recommendation is to primarily use Libre Rio since it is specifically designed for them. The company declined to share when Libre Rio will be available.

The Lingo app

Abbott’s Lingo app.

Courtesy of Abbott

Like many continuous glucose monitors, Lingo transmits data wirelessly to an app. When users open it, they’ll see a real-time reading of their glucose data that’s updated every minute. 

Those glucose readings are plotted on a graph, which includes a shaded area to indicate a “healthy range.” Fohner said Abbott’s clinical team defines this range as 140 milligrams per deciliter to 70 milligrams per deciliter.

One of Abbott’s primary goals is to help Lingo users learn about glucose spikes, which occur when the amount of sugar present in the bloodstream rapidly increases and then decreases. Glucose spikes commonly occur after eating. 

Spikes can push a user’s glucose reading above the healthy range, but they can also occur within the healthy range. Limiting spikes and improving glucose management overall can help users improve their sleep and mood, manage their weight, and be proactive about their future health, Abbott said.

To help users conceptualize the impact of their spikes, Abbott created a metric called the “Lingo Count.” It’s an algorithm that assigns a numeric value to each glucose spike, and it’s supposed to represent how significant the impact is. Over each day, users have a target Lingo Count that they want to aim to stay below. 

Abbott’s Lingo app.

Courtesy of Abbott

Users can see this data represented on a second, more interactive glucose graph when they scroll down Lingo’s home page. A number will appear in the shaded area beneath a spike, which represents the Lingo Count for that spike. 

“It’s unique to Lingo, but really that number is an indicator and a function of, how high did your spike go, how long did it last, and what was the impact that that spike had on your body,” Fohner said. 

Users can analyze Lingo Count data and see how they are doing over time, as well as what time of day they tend to experience the most dramatic spikes. They can also participate in challenges and access educational resources to learn how to reduce those spikes.  

Ropars said metabolism doesn’t change overnight, and everyone’s bodies work differently. He said Lingo can serve as a window into how and why a user’s glucose levels vary. But the real value of Lingo, Ropars said, is the support it can offer users as they try to establish healthy habits.

“A lot of our products today are geared toward helping people that are experiencing a chronic disease or sickness and trying to get back on track,” he said. “Here, this is the first time we’re doing a product that is helping people, improving their daily life, taking control of their health before they get sick”

Don’t miss these insights from CNBC PRO

Related Topics:
Continue Reading

Technology

Amazon was questioned by House China committee over ‘dangerous and unwise’ TikTok partnership

Published

15 hours ago

on

November 14, 2024

By

Amazon was questioned by House China committee over 'dangerous and unwise' TikTok partnership

Amazon logo on a brick building exterior, San Francisco, California, August 20, 2024.

Smith Collection | Gado | Archive Photos | Getty Images

Amazon representatives met with the House China committee in recent months to discuss lawmaker concerns over the company’s partnership with TikTok, CNBC confirmed.

A spokesperson for the House Select Committee on the Chinese Communist Party confirmed the meeting, which centered on a shopping deal between Amazon and TikTok announced in August. The agreement allows users of TikTok, owned by China’s ByteDance, to link their account with Amazon and make purchases from the site without leaving TikTok.

“The Select Committee conveyed to Amazon that it is dangerous and unwise for Amazon to partner with TikTok given the grave national security threat the app poses,” the spokesperson said. The parties met in September, according to Bloomberg, which first reported the news.

Representatives from Amazon and TikTok did not immediately respond to CNBC’s request for comment.

TikTok’s future viability in the U.S. is uncertain. In April, President Joe Biden signed a law that requires ByteDance to sell TikTok by Jan. 19. If TikTok fails to cut ties with its parent company, app stores and internet hosting services would be prohibited from offering the app.

President-elect Donald Trump could rescue TikTok from a potential U.S. ban. He promised on the campaign trail that he would “save” TikTok, and said in a March interview with CNBC’s “Squawk Box” that “there’s a lot of good and there’s a lot of bad” with the app.

In his first administration, Trump had tried to implement a TikTok ban. He changed his stance around the time he met with billionaire Jeff Yass. The Republican megadonor’s trading firm, Susquehanna International Group, owns a 15% stake in ByteDance, while Yass has a 7% stake in the company, NBC and CNBC reported in March.

— CNBC’s Jonathan Vanian contributed to this report.

Don’t miss these insights from CNBC PRO

TikTok is 'digital nicotine' for young people, says D.C. Attorney General Brian Schwalb

Continue Reading

Technology

Amazon launches fixed pricing for treatment of conditions such as hair loss. Hims & Hers stock drops 15%

Published

21 hours ago

on

November 14, 2024

By

Amazon launches fixed pricing for treatment of conditions such as hair loss. Hims & Hers stock drops 15%

A worker delivers Amazon packages in San Francisco on Oct. 24, 2024.

David Paul Morris | Bloomberg | Getty Images

Amazon on Thursday announced Prime members can access new fixed pricing for treatment of conditions like erectile dysfunction and men’s hair loss, its latest effort to compete with other direct-to-consumer marketplaces such as Hims & Hers Health and Ro.

Shares of Hims & Hers fell as much as 17% on Thursday, on pace for its worst day.

Amazon said in a blog post that Prime members can see the cost of a telehealth visit and their desired treatment before they decide to proceed with care for five common issues. Patients can access treatment for anti-aging skin care starting at $10 a month; motion sickness for $2 per use; erectile dysfunction at $19 a month; eyelash growth at $43 a month, and men’s hair loss for $16 a month by using Amazon’s savings benefit Prime Rx at checkout.

Amazon acquired primary care provider One Medical for roughly $3.9 billion in July 2022, and Thursday’s announcement builds on its existing pay-per-visit telehealth offering. Video visits through the service cost $49, and messaging visits cost $29 where available. Users can get treatment for more than 30 common conditions, including sinus infection and pink eye.

Medications filled through Amazon Pharmacy are eligible for discounted pricing and will be delivered to patients’ doors in standard Amazon packaging. Prime members will pay for the consultation and medication, but there are no additional fees, the blog post said.

Amazon has been trying to break into the lucrative health-care sector for years. The company launched its own online pharmacy in 2020 following its acquisition of PillPack in 2018. Amazon introduced, and later shuttered, a telehealth service called Amazon Care, as well as a line of health and wellness devices.

The company has also discontinued a secretive effort to develop an at-home fertility tracker, CNBC reported Wednesday.

— CNBC’s Annie Palmer contributed to this report.

Continue Reading

Technology

WikiLeaks whistleblower Chelsea Manning says censorship is still ‘a dominant threat’

Published

24 hours ago

on

November 14, 2024

By

WikiLeaks whistleblower Chelsea Manning says censorship is still 'a dominant threat'

Chelsea Manning: Censorship still a dominant threat

Former U.S. Army intelligence analyst Chelsea Manning says censorship is still “a dominant threat,” advocating for a more decentralized internet to help better protect individuals online.

Her comments come amid ongoing tension linked to online safety rules, with some tech executives recently seeking to push back over content moderation concerns.

Speaking to CNBC’s Karen Tso at the Web Summit tech conference in Lisbon, Portugal, on Wednesday, Manning said that one way to ensure online privacy could be “decentralized identification,” which gives individuals the ability to control their own data.

“Censorship is a dominant threat. I think that it is a question of who’s doing the censoring, and what the purpose is — and also censorship in the 21st century is more about whether or not you’re boosted through like an algorithm, and how the fine-tuning of that seems to work,” Manning said.

“I think that social media and the monopolies of social media have sort of gotten us used to the fact that certain things that drive engagement will be attractive,” she added.

“One of the ways that we can sort of countervail that is to go back to the more decentralized and distribute the internet of the early ’90s, but make that available to more people.”

Nym Technologies Chief Security Officer Chelsea Manning at a press conference held with Nym Technologies CEO Harry Halpin in the Media Village to present NymVPN during the second day of Web Summit on November 13, 2024 in Lisbon, Portugal. 

Horacio Villalobos | Getty Images News | Getty Images

Asked how tech companies could make money in such a scenario, Manning said there would have to be “a better social contract” put in place to determine how information is shared and accessed.

“One of the things about distributed or decentralized identification is that through encryption you’re able to sort of check the box yourself, instead of having to depend on the company to provide you with a check box or an accept here, you’re making that decision from a technical perspective,” Manning said.

‘No longer secrecy versus transparency’

Manning, who works as a security consultant at Nym Technologies, a company that specializes in online privacy and security, was convicted of espionage and other charges at a court-martial in 2013 for leaking a trove of secret military files to online media publisher WikiLeaks.

She was sentenced to 35 years in prison, but was later released in 2017, when former U.S. President Barack Obama commuted her sentence.

Asked to what extent the environment has changed for whistleblowers today, Manning said, “We’re at an interesting time because information is everywhere. We have more information than ever.”

She added, “Countries and governments no longer seem to invest the same amount of time and effort in hiding information and keeping secrets. What countries seem to be doing now is they seem to be spending more time and energy spreading misinformation and disinformation.”

Manning said the challenge for whistleblowers now is to sort through the information to understand what is verifiable and authentic.

“It’s no longer secrecy versus transparency,” she added.

Continue Reading

Trending